Facebook Linkedin Soundcloud X Vimeo Xing
Home Package Inserts -Antibody-drug Conjugates

Package Inserts -Antibody-drug Conjugates

Highlights of Prescribing Information

U.S. Food and Drug Adminstration (FDA) Approved and Commercially available Antibody-drug Conjugates (ADC)

Antibody-drug Conjugates

The information on this page is limited to commercially available antibody-drug conjugates (ADCs) approved by the U.S. Food and Drug Administration (FDA) and intended for healthcare professionals (HCP) only. If you are not a U.S. healthcare professional, do not continue on this page.

 Year Approved**
Drug (INN)*Trade NameDeveloperFDA
Gemtuzumab OzogamicinMYLOTARG™Wyeth/Pfizer2000
(Witdrawn)
Gemtuzumab OzogamicinMYLOTARG™Wyeth/Pfizer2017 (Reintroduced)
Brentuximab VedodinAdcetris®Seagen /Takeda2011
Ado-trastuzumab emtansineKadcyla®Genentech /Roche2013
Inotuzumab OzogamicinBesponsa®Wyeth /Pfizer2017
Polatuzumab vedotin-piiqPolivy™Genentech /Roche2019
Enfortumab Vedotin-ejfvPadcev™Astellas /Seattle Genetics2019
Fam-trastuzumab deruxtecan-nxkiEnhertu®Daiichi Sankyo /AstraZeneca2019
Belantamab mafodotin-blmfBlenrep™GSK /GlaxoSmithKline2020
Belantamab mafodotin-blmfBlenrep™GSK /GlaxoSmithKline2022
(Withdrawn)
Sacituzumab govitecan-hziyTrodelvy™Gilead /Immunomedics2020
Tisotumab Vedotin-tftvTivdak®Seagen/Genmab2021
Loncastuximab tesirine-lpylZynlonta®ADC Therapeutics2021
Mirvetuximab soravtansine-gynxElahere®ImmunoGen2022
    
    

* Link to drug description ** Link to package insert

This material is developed and provided for educational purposes only. This information is NOT intended for medical advice, diagnosis or treatment . Always consult the latest prescription information for Important Safety Information, including BOXED WARNINGS.

Join Our ADC Community

As a member of the ADC Directory, share your expertise, discover new solutions, network with peers and grow your business. Click on the link for more information.

LEARN MORE

ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2024 Sunvalley Communication, LLC. All Rights Reserved.

X